Where does Medartis AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medartis AG ranks #9,554 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medartis AG hold?

Medartis AG holds 33 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Medartis AG's Innovation Score?

Medartis AG has an Innovation Score of 50.3 out of 100 (top 13% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medartis AG focus on?

Medartis AG's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 30 patents, ranking #624 of 7,127 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Medartis AG's patent grant rate increasing or decreasing?

Medartis AG's recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Medartis AG's patents?

Medartis AG's patents average 13.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medartis AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medartis AG

USPTO PatentsView assignee record - 33 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medartis ranks #9,554 of 49,997 tracked US assignees by granted-patent volume, with 33 patents across 8 technology areas.

#9,554
of 49,997 US assignees by volume: Top 13%
by Innovation Score (50.3/100): 13.6
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9554 · Foreign Corporation #9,554 · 33 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 33 grants
UPPER-Q #9,554/49,997
PHOTO-FINISH Malzine
CPC-NARROW A61B · 8 areas
INNOV-PAR 50.3/100
CLAIMS-RICH 13.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Malzine Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medartis’s 50.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.2 pts (24%) Velocity 20.0 pts (40%) Breadth 10.0 pts (20%) Claim depth 8.2 pts (16%)

Qualcomm Incorporated · highest

85
Medartis · this assignee

50
National University… · near

50
National University… · near

50
Telesair · near

50
Wagner Spray Tech · near

50
3D Lighting… · lowest

7

What this shows Medartis's Innovation Score is 50.3/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medartis?

Each dot is one of Medartis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medartis’s own 13.6 claims/patent is ABOVE the 10.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medartis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medartis's grants concentrate

Medartis AG is a focused PatentsView assignee: 8 CPC subclasses with 90.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (8 grants) versus a trough of 1 in 2017. By volume, Medartis sits between Malzine Co., Ltd. and Montage Technology (SHANGHAI) Co., Ltd..

Medartis's three-year grant acceleration

Medartis AG shows 19 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Malzine

33
Mapa

33
Marel Stork Poult…

33
Martor KG

33
Metawater

33
Modular Mining Sy…

33
Modumetal

33
Montage Technolog…

33
Medartis ◀

33

What this shows Medartis holds 33 patents at rank #9,552, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medartis

By rank, the assignees closest to #9,552 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medartis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medartis, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Medartis ranks #624 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (50 here).

National University Corporation University of Toyama 50 Wagner Spray Tech Corporation 50 National University Corporation Gunma University 50 Telesair, Inc. 50

Medartis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 13% higher than 87% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Medartis AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	6.1%
2016	2	6.1%
2017	1	3.0%
2019	1	3.0%
2020	5	15.2%
2022	3	9.1%
2023	8	24.2%
2024	8	24.2%
2025partial year	3	9.1%

Which technologies does Medartis AG patent most?

A61B - DIAGNOSIS; SURGERY; Identification 30

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 8

F16B - Devices FOR Fastening OR Securing Constructional Elements OR Machine Parts Together, e.g. Nails, Bolts, Circlips, Clamps, Clips OR WEDGES; Joints OR Jointing 1

H01M - Processes OR Means, e.g. Batteries, FOR THE Direct Conversion OF Chemical Energy Into Electrical Energy 1

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 1

B25F - Combination OR Multi-purpose Tools NOT Otherwise Provided FOR; Details OR Components OF Portable Power-driven Tools NOT Particularly Related TO THE Operations Performed AND NOT Otherwise Provided FOR 1

B25G - Handles FOR Hand Implements 1

B25B - Tools OR Bench Devices NOT Otherwise Provided FOR, FOR Fastening, Connecting, Disengaging OR Holding 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medartis AG's patent record in context - here's where to go next.

Medartis AG's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 90.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #9,554 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medartis AG against Malzine Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.